BIS Monitor Anesthesia for Neurocognitive Disorder
(POEGEA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method of using anesthesia during major surgeries to prevent memory and thinking problems afterward. It compares standard anesthesia to a method that uses special brain monitoring (EEG) to guide the anesthesia, known as EEG-guided anesthesia. The trial seeks participants aged 70 or older undergoing major surgeries, such as gynecologic or orthopedic procedures, expected to last over an hour. The goal is to determine if this new method can reduce memory issues shortly after surgery and over time. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance surgical outcomes for older adults.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that EEG-guided anesthesia is safe for patients undergoing major non-cardiac surgery?
Research has shown that EEG-guided anesthesia is generally safe for patients. One study found that patients who received EEG-guided anesthesia had a 1.4% chance of dying within thirty days, compared to a 2.3% chance in the group that received usual care, suggesting it might be safer. Other studies suggest that EEG guidance during anesthesia may reduce the risk of postoperative delirium, or confusion after surgery.
While these findings are encouraging, researchers continue to study the safety of EEG-guided anesthesia, especially in older patients. Overall, results so far indicate that this method is well-tolerated. Always consult a healthcare provider if there are concerns about joining a clinical trial.12345Why are researchers excited about this trial?
Researchers are excited about EEG-guided anesthesia for neurocognitive disorders because it uses real-time brain monitoring to tailor anesthesia levels. Unlike standard care, which relies on set dosages of anesthetics like sevoflurane, this method adjusts anesthesia based on brain activity, potentially reducing over-sedation and improving recovery. This approach promises more personalized anesthesia management, which could lead to fewer complications and a smoother recovery for patients with neurocognitive disorders.
What evidence suggests that EEG-guided anesthesia is effective for preventing postoperative neurocognitive disorders?
Research has shown that brain wave monitoring during anesthesia can reduce the risk of memory and thinking problems after surgery, known as postoperative neurocognitive disorder (NCD). In this trial, participants in the Electroencephalographic (EEG)-guided group will have their anesthesia directed by BIS monitoring, which studies have found decreases the likelihood of these issues. One study discovered that brain wave guidance resulted in fewer cases of confusion and better mental function post-surgery. Another analysis showed that this approach significantly reduced memory and thinking problems in patients. These findings suggest that brain wave monitoring during anesthesia could effectively protect brain health during and after surgery, especially for older adults.26789
Who Is on the Research Team?
Philippe Richebé, MD, PhD
Principal Investigator
Hôpital Maisonneuve-Rosemont - CIUSSS de l'Est de l'Ile de Montréal - Canada
Are You a Good Fit for This Trial?
This trial is for patients aged 70 or older who are undergoing major non-cardiac surgery and have an expected anesthesia time over 60 minutes. They must be able to communicate in English or French, without severe cognitive impairments from conditions like dementia, and not require emergency surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo EEG-guided or standard care anesthesia during major non-cardiac surgery
Postoperative Monitoring
Participants are assessed for neurocognitive disorders and other outcomes at multiple postoperative timepoints
Follow-up
Participants are monitored for long-term cognitive outcomes and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Electroencephalic (EEG)-guided anesthesia
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ciusss de L'Est de l'Île de Montréal
Lead Sponsor
Medtronic
Industry Sponsor
Geoff Martha
Medtronic
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. Richard Kuntz
Medtronic
Chief Medical Officer since 2023
MD, MSc